SCHEMBL183532

SCHEMBL183532

CC(=O)c1ccc(C)o1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL54682 0.84 KMT2A (0.46) —
SCHEMBL19681459 0.82 KLK7 (0.57) —
SCHEMBL9349735 0.82 KLK7 (0.57) —
SCHEMBL11539386 0.81 KLK7 (0.52) —
SCHEMBL143244 0.80 — —
SCHEMBL10675360 0.79 — —
SCHEMBL353183 0.78 — —
SCHEMBL279424 0.78 — —
Hydrochloric Acid SCHEMBL3047201 0.78 KLK7 (0.53) —
SCHEMBL28967674 0.78 KLK7 (0.53) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1070 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260096574-A1 CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS VOYAGE FOODS INC (US) 2026-04-09 — — US claimed
US-20260007144-A1 CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS VOYAGE FOODS INC (US) 2026-01-08 — — US claimed
EP-4672967-A2 ALTERNATIVE COFFEE BEVERAGES Compound Foods Inc. (US) 2026-01-07 — — EP claimed
US-12496370-B2 Freshening compositions comprising controlled release modulators Arylessence, Inc. (US) 2025-12-16 — — US claimed
US-20250344991-A1 COMPOSITIONS AND METHODS FOR A UNIVERSAL CLINICAL TEST FOR OLFACTORY DYSFUNCTION UNIV ROCKEFELLER (US) 2025-11-13 — — US claimed
EP-4627940-A1 COMPOSITIONS AND METHODS Nicoventures Trading Limited (GB) 2025-10-08 — — EP claimed
EP-4627939-A1 METHODS Nicoventures Trading Limited (GB) 2025-10-08 — — EP claimed
EP-4627942-A1 COMPOSITIONS AND METHODS Nicoventures Trading Limited (GB) 2025-10-08 — — EP claimed
EP-4627941-A1 COMPOSITIONS AND METHODS Nicoventures Trading Limited (GB) 2025-10-08 — — EP claimed
EP-4627943-A1 COMPOSITIONS AND METHODS Nicoventures Trading Limited (GB) 2025-10-08 — — EP claimed
EP-2517573-A1 FLAVOR-IMPROVING MATERIAL Ajinomoto Co., Inc. (JP) 2012-10-31 — — EP claimed
US-20120269947-A1 FLAVOR IMPROVING MATERIALS AJINOMOTO CO., INC. (JP) 2012-10-25 — — US claimed
CN-102503894-A 5-substituted methylene imidazolidine-2, 4-diketone derivative as well as pharmaceutical composition and application thereof UNIV TIANJIN MEDICAL 2012-06-20 — — CN claimed
US-7572757-B1 Method of treating a well with a gel stabilizer BJ SERVICES COMPANY (US) 2009-08-11 — — US claimed
US-20050124684-A1 5-(hydroxymethyl) furfural and derivatives as inhibitors of TNFalpha and IL-1beta production HUTCHISON MEDIPHARMA ENTERPRISES LIMITED (BS) 2005-06-09 — — US claimed
US-20040185347-A1 Non-aqueous electrolyte and a lithium secondary battery comprising the same SAMSUNG SDI CO., LTD. (KR) 2004-09-23 — — US claimed
EP-1458048-A1 A non-aqueous electrolyte and a lithium secondary battery comprising the same Samsung SDI Co., Ltd. (KR) 2004-09-15 — — EP claimed
EP-0674233-B1 Recording sheets XEROX CORP (US) 2000-05-24 — — EP claimed
US-5928765-A Recording sheets XEROX CORPORATION (US) 1999-07-27 — — US claimed
EP-0674233-A2 Recording sheets XEROX CORPORATION (US) 1995-09-27 — — EP claimed
Send feedback